The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 468.00
Bid: 460.00
Ask: 470.00
Change: 3.00 (0.65%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 468.00
Low: 468.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Notification

24 Nov 2022 09:13

RNS Number : 4951H
Aquis Exchange PLC
24 November 2022
 

24 November 2022

Aquis Exchange PLC ("Aquis Exchange")Director/PDMR Notification

Aquis Exchange PLC makes the following announcement regarding its Directors' participation in the Aquis Share Incentive Plan.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

CEO

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 

 

GB00BD5JNK30

b)

Nature of the transaction

Alasdair Haynes participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

430p

837

d)

Aggregated information

- Aggregated volume

 

 - Price

 

 

837

 

 

430p

 

e)

Date of the transaction

23 November 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Richard Fisher

2.

Reason for the notification

b)

Position / status

CFO

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 

 

GB00BD5JNK30

b)

Nature of the transaction

Richard Fisher participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

430p

837

 

d)

Aggregated information

- Aggregated volume

 

 - Price

 

 

837

 

 

430p

 

e)

Date of the transaction

23 November 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

 

a)

Position / status

COO

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 

 

GB00BD5JNK30

b)

Nature of the transaction

Jonathan Clelland participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

430p

837

 

d)

Aggregated information

- Aggregated volume

 

- Price

 

 

837

 

 

430p

 

e)

Date of the transaction

23 November 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

Enquiries:

Aquis Exchange PLC

Alasdair Haynes, CEO

Richard Fisher, CFO

Adele Gilbert, Head of Marketing

Andrea Lee

 

Tel: +44 (0) 20 3597 6321

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

Pascal Wiese

 

Tel: +44(0)20 3005 5000

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Chris Clarke

Clayton Bush

Edward Thomas

Kane Collings

 

Tel: +44 (0) 20 3100 2000

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

Patrick Dolaghan

 

Tel: +44 (0) 20 7523 8000

Alma PR (Financial PR Adviser)

Caroline Forde

Kieran Breheny

Lily Soares Smith

Pippa Crabtree

 

Tel: +44 (0) 20 3405 0209

Website:

http://www.aquis.eu

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLALILSFIF
Date   Source Headline
26th May 20227:00 amRNSChange of registered address
29th Apr 20221:57 pmRNSDirector/PDMR Notification and Issue of Options
26th Apr 20223:05 pmRNSBoard Appointments
26th Apr 20222:59 pmRNSResult of AGM
4th Apr 20228:18 amRNSPublication of Annual Report and Notice of AGM
4th Apr 20227:00 amRNSDirector/PDMR Dealing
1st Apr 20223:53 pmRNSTransfer of UBS MTF Business Activities Completed
30th Mar 20229:35 amRNSExercise of Share Options and Total Voting Rights
29th Mar 20227:10 amRNSFinal Results and Board Appointments
29th Mar 20227:00 amRNSAdmission to Trading on the AQSE Growth Market
16th Mar 20227:00 amRNSTransfer of UBS MTF business activities to Aquis
11th Mar 20227:00 amRNSIntention to Dual List on the AQSE
24th Feb 20227:00 amRNSNotice of Results
8th Feb 20227:00 amRNSAquis Technologies partners with Investre
26th Nov 20219:48 amRNSExercise of Share Options and Total Voting Rights
26th Nov 20217:00 amRNSAppointment of New Chair
25th Nov 20217:00 amRNSDirector/PDMR Notification
23rd Sep 20215:39 pmRNSExercise of Share Options, Director Dealing & TVR
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20217:00 amRNSBoard Appointment
1st Sep 20217:00 amRNSNotice of Results
25th Aug 20217:00 amRNSAppointment of independent NED to AQSE Board
2nd Aug 20217:00 amRNSAquis Exchange achieves record market share
28th Jun 20214:21 pmRNSExercise of Share Options and Director Dealing
27th May 20217:00 amRNSAQSE expands research for its top-tier stocks
18th May 20217:00 amRNSDual quotations with the Frankfurt Stock Exchange
13th May 20217:00 amRNSNew Senior Management Appointments
30th Apr 20217:00 amRNSDirector/PDMR Notification & Issue of Options
27th Apr 202112:41 pmRNSResult of Annual General Meeting
8th Apr 20217:00 amRNSDirector/PDMR Notification
31st Mar 20214:51 pmRNSPublication of ARA and Notice of AGM
31st Mar 20217:00 amRNSFinal Results
26th Mar 20217:00 amRNSNotice of Results
24th Mar 20217:00 amRNSAquis Exchange and ShareSoc Retail Investor Survey
26th Feb 20217:00 amRNSTrading and Operational Update
5th Feb 202112:07 pmRNSAppointment of Joint Broker
4th Feb 20218:03 amRNSAquis Exchange recommences trading in Swiss shares
14th Dec 20207:00 amRNSAQSE rule changes & market segments now in effect
26th Nov 20207:00 amRNSDirector/PDMR Notification
23rd Nov 20207:00 amRNSAQSE launches Market Maker Incentive Scheme
20th Nov 20202:00 pmRNSAquis works with SGX & AWS on cloud deployment
19th Oct 20207:00 amRNSAppointment to the AQSE Board
12th Oct 20207:00 amRNSAppointment of Independent Non-executive Director
9th Sep 20207:00 amRNSInterim Results
27th Aug 20207:00 amRNSNotice of Results
17th Jun 20207:00 amRNSBoard Appointment
16th Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:01 amRNSDirector/PDMR Notification
15th Jun 20207:00 amRNSIssue of Options and Director/PDMR Notification
19th May 20201:26 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.